Screener
Pacira BioSciences, Inc. PCRX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
FAQ
- What is Pacira BioSciences, Inc.'s invested capital?
- Pacira BioSciences, Inc. (PCRX) reported invested capital of $920.77M in Q1 2026.
- How has Pacira BioSciences, Inc.'s invested capital changed year-over-year?
- Pacira BioSciences, Inc.'s invested capital increased by 5.6% year-over-year, from $871.59M to $920.77M.
- What is the long-term trend for Pacira BioSciences, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s invested capital has grown at a 5.0% compound annual growth rate (CAGR), from $747.83M to $952.77M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Pacira BioSciences, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude